| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/25/2002 | CN1371388A Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis |
| 09/25/2002 | CN1371374A Substituted heterocycle fused gamma-carbolines |
| 09/25/2002 | CN1371365A Piperidine alcohols |
| 09/25/2002 | CN1371280A Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 09/25/2002 | CN1371277A Pharmaceutical tramadol salts |
| 09/25/2002 | CN1370843A Functions of Tob gene in central nervous system of mammol and its application |
| 09/25/2002 | CN1370592A Chinese meidcine composition for preventing and treating senile dementia |
| 09/25/2002 | CN1370589A Sobering-up toxin-eliminating tea and its prepn |
| 09/25/2002 | CN1370586A Medicinal use of common valeriana extractive with organic solvent |
| 09/25/2002 | CN1370554A Kidney-benefiting and tranquilizing medicine and its prepn |
| 09/25/2002 | CN1370553A Brain-invigorating tic-stopping medicine and its prepn |
| 09/25/2002 | CN1370545A Chinese medicine prepn for giving up drinking and its prepn process |
| 09/25/2002 | CN1370542A Heterogenous phaeochrome cell micrpcapsule and its prepn |
| 09/25/2002 | CN1370541A Chinese medicine prepn for treating schizophrenia |
| 09/25/2002 | CN1370528A Medicine for treating insomnia and mental disturbance |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |
| 09/25/2002 | CN1370429A Health food |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/25/2002 | CN1091382C Compound lingxian headache treating medicine and its preparation |
| 09/25/2002 | CN1091380C Preparation method of medicine huaqi huannao dan for curing encephalomyelopathy |
| 09/25/2002 | CN1091372C Medicine for curing brain dysfunction and epilepsy |
| 09/25/2002 | CN1091370C Usage of schube thinamine in preparation of medicinal composition for treating mental motional and psychological intelligent diseases |
| 09/24/2002 | US6455734 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 09/24/2002 | US6455710 Method for the preparation of pure citalopram |
| 09/24/2002 | US6455698 Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| 09/24/2002 | US6455585 Have a higher analgesic activity, a lower toxicity and a longer effective time period than tramadol. |
| 09/24/2002 | US6455582 Treating cancer |
| 09/24/2002 | US6455578 Aromatic derivatives and iron complexes thereof for the use as normalizing agents of the iron level |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455545 Gastrointestinal disorders |
| 09/24/2002 | US6455544 Use of cholinesterase inhibitors to treat disorders of attention |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455538 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ols |
| 09/24/2002 | US6455537 Methods for treating opiate intolerance |
| 09/24/2002 | US6455536 Treatment of dyskinesia |
| 09/24/2002 | US6455533 Substituted benzhydrylpiperazines such as cetirizine, hydroxyzine, efletirizine, meclizine and buclizine, the optically active isomers thereof and the pharmaceutically acceptable salts thereof. |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455521 Psychological disorders; side effect reduction |
| 09/24/2002 | US6455516 Administering epiallopregnanolone as antidepressant, cognition activator, or antiepileptic agent; treatment of premenstrual syndrome |
| 09/24/2002 | US6455510 Chemical Compounds |
| 09/24/2002 | US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455078 Grinding and mixing the plant of diffuse hedyotis, dried rhizome of bistort rhizome, giant knotweed rhizome, dried ripe fruit of chinese magnoliviavine fruit to form mixture, boiling in water, filtering and concentrating the extract |
| 09/24/2002 | US6455066 Intradermal-penetration agents for topical local anesthetic administration |
| 09/24/2002 | CA2261426C Benzimidazole cyclooxygenase-2-inhibitors |
| 09/24/2002 | CA2246584C Method of treating tourette's syndrome |
| 09/23/2002 | WO2001070689A1 DIPHENYLALKYLAMINE DERIVATIVES USEFUL AS OPIOID δ RECEPTOR AGONISTS |
| 09/23/2002 | CA2404280A1 Diphenylalkylamine derivatives useful as opioid .delta. receptor agonists |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/20/2002 | CA2403732A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072827A1 Traf3-binding b cell-specific receptor |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072599A1 Anti-apoptosis agents or regeneration promoters comprising ginsenosides |
| 09/19/2002 | WO2002072587A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline |
| 09/19/2002 | WO2002072585A2 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 09/19/2002 | WO2002072584A2 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072573A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. |
| 09/19/2002 | WO2002072571A2 Pyridinyl pyrazoles useful for the treatment of copd |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
| 09/19/2002 | WO2002072550A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics |
| 09/19/2002 | WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands. |
| 09/19/2002 | WO2002072542A2 Ph-dependent nmda receptor antagonists |
| 09/19/2002 | WO2002072536A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 09/19/2002 | WO2002072528A1 Fluorinated trienes and their use as rxr modulators |
| 09/19/2002 | WO2002072448A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072145A1 Remedies for depression containing ep1 antagonist as the active ingredient |
| 09/19/2002 | WO2002072144A1 Remedies for nerve damages |
| 09/19/2002 | WO2002072125A1 Methods of reducing beta-amyloid polypeptides |
| 09/19/2002 | WO2002072124A1 Composition containing asiasari radix extracts for protecting brain cells and improving memory |
| 09/19/2002 | WO2002072120A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 09/19/2002 | WO2002072114A2 Extracts of magnoliaceae plants and their use as anxiolytic and sedative agent |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002072094A2 Use of neuroactive substances and combinations thereof for the treatment of parkinsons disease |
| 09/19/2002 | WO2002072093A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 09/19/2002 | WO2002072089A2 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | WO2002072088A2 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/19/2002 | WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 09/19/2002 | WO2002072029A2 Dopamine d4 receptor antagonists as treatment for attention deficit-hyperactivity disorder |
| 09/19/2002 | WO2002072005A2 Linear y-carboxyglutamate rich conotoxins |